<?xml version="1.0"?><?xml-stylesheet type="text/xsl" href="drug-table.xslt"?><drug name = "cytarabine liposome (SAP) inj VIAL">
<dose><value>50</value>
</dose>
<route><value>INTRATHECAL</value>
</route>
<strength><value>10 mg/mL</value>
</strength>
<frequency><value>EVERY 14 DAYS</value>
<value>ONCE</value>
<value>EVERY 28 DAYS</value>
</frequency>
<instruction><value>for 2 doses.</value>
<value>Administer at week 5.</value>
<value>Administer at week 7.</value>
<value>Administer at week 9.</value>
<value>Administer at week 13.</value>
<value>for 4 doses.</value>
</instruction>
<volume><value>5 mL</value>
</volume>
<units><value>mg</value>
</units>
<Population><value>ADULT</value>
</Population>
<IndicationPRN></IndicationPRN>
<AdditionalNotes><value>Solid Tunor Neoplastic Meningitis: Induction</value>
<value>Solid Tunor Neoplastic Meningitis: Consolidation. Administer at week 5, 7, 9, and 13 for a total of 4 doses.</value>
<value>Lymphomatous meningitis: Induction</value>
<value>Lymphomatous meningitis: Consolidation. Administer at week 5, 7, 9, and 13 for a total of 4 doses.</value>
<value>Lymphomatous meningitis: Maintenance</value>
</AdditionalNotes>
<BackgroundInformation><value>http://intraweb01.albertahealthservices.ca/Pharmacy/AHS_FORMULARY/search_details.aspx?id=3469</value>
</BackgroundInformation>
<PRNInformation></PRNInformation>
<AHSFormularyStatus><value>FSAP</value>
</AHSFormularyStatus>
<HighAlert><value>HIGH ALERT MEDICATION</value>
</HighAlert>
</drug>